Maravai Lifesciences Holdings (MRVI) Interest & Investment Income (2022 - 2026)

Maravai Lifesciences Holdings' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• On a quarterly basis, Interest & Investment Income fell 41.92% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $10.1 million, a 56.94% decrease from a year earlier, with the FY2025 full-year figure at $11.4 million, down 58.27% from the prior year.
• Interest & Investment Income declined to $1.9 million in Q1 2026 per MRVI's latest filing, from $2.4 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $7.5 million in Q4 2023 and bottomed at $1.9 million in Q1 2026.
• The 5-year median for Interest & Investment Income is $6.0 million (2023), against an average of $5.1 million.
• Across the five-year window, Interest & Investment Income jumped 219.03% in 2023 and sank 60.5% in 2025, its largest moves.
• Year by year, Interest & Investment Income stood at $2.3 million in 2022, then soared by 219.03% to $7.5 million in 2023, then fell by 19.08% to $6.0 million in 2024, then slumped by 60.5% to $2.4 million in 2025, then fell by 21.43% to $1.9 million in 2026.
• Per Business Quant, the three latest MRVI Interest & Investment Income figures stand at $1.9 million (Q1 2026), $2.4 million (Q4 2025), and $2.8 million (Q3 2025).